International Stem Cell (ISCO) Intangibles (2010 - 2026)
International Stem Cell (ISCO) posted quarterly Intangibles of $75000.0 for Q4 2025, down 88.39% year-over-year from $646000.0 in Q4 2024, and down 88.65% quarter-over-quarter from $661000.0 in Q3 2025.
International Stem Cell (ISCO) Intangibles (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Intangibles for 16 consecutive years, with $75000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Intangibles fell 88.39% year-over-year to $75000.0; the TTM figure through Dec 2025 stood at $75000.0 (down 88.39% YoY), while the FY2025 annual figure was $75000.0, down 88.39% from the prior year.
- Intangibles retreated to $75000.0 in Q4 2025 per ISCO's latest filing, from $661000.0 in the prior quarter.
- Across five years, Intangibles topped out at $1.2 million in Q1 2021 and bottomed at $75000.0 in Q1 2024.
- Historically, Intangibles has averaged $736350.0 across 5 years, with a median of $781000.0 in 2023.
- Annual changes were most pronounced in 2024 — Intangibles tumbled 91.26% — and 2025, when it changed 0.0%.
- International Stem Cell's Intangibles stood at $949000.0 in 2021, then retreated by 7.48% to $878000.0 in 2022, then declined by 8.88% to $800000.0 in 2023, then dropped by 19.25% to $646000.0 in 2024, then sank by 88.39% to $75000.0 in 2025.
- Business Quant data shows ISCO's Intangibles at $75000.0 in Q4 2025, $661000.0 in Q3 2025, and $681000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn | 515,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 515,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Sep 30, 2025 | 661,000.00 |
| Jun 30, 2025 | 681,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | 646,000.00 |
| Sep 30, 2024 | 664,000.00 |
| Jun 30, 2024 | 683,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 742,000.00 |
| Jun 30, 2023 | 762,000.00 |
| Mar 31, 2023 | 858,000.00 |
| Dec 31, 2022 | 878,000.00 |
| Sep 30, 2022 | 896,000.00 |
| Jun 30, 2022 | 917,000.00 |
| Mar 31, 2022 | 933,000.00 |
| Dec 31, 2021 | 949,000.00 |
| Sep 30, 2021 | 962,000.00 |
| Jun 30, 2021 | 1.23 Mn |